Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Angiogenin ELISA Kit (AC3085)
Cat.#: ASET-1674
Specifications
Description Mouse Angiogenin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Angiogenin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.78 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1902 Human Apolipoprotein E ELISA Kit (AC3313) Quantitative inquiry ASET-1688 Human VEGFC ELISA Kit (AC3099) Quantitative inquiry ASET-2195 Human PTPRS ELISA Kit (AC3606) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-2294 Human Hes1 ELISA Kit (AC3705) Quantitative inquiry ASET-1534 Human Apolipoprotein E ELISA Kit (AC2945) Quantitative inquiry ASET-2071 Rat beta Endorphin ELISA Kit (AC3482) Quantitative inquiry ASET-2035 Mouse CD11b ELISA Kit (AC3446) Quantitative inquiry ASET-1038 Rat ULK1 ELISA Kit (AC2449) Quantitative inquiry ASET-2123 Human CD147 ELISA Kit (AC3534) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket